ArticleHemaSphere2022

Genotype and Intensive Pretreatment Influence Outcome of Acute Myeloid Leukemia Patients Treated With Venetoclax in Combination With Hypomethylating Agents or Low-dose Cytarabine: "Real World" Data From Germany.

Krischan Braitsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.